Akums Drugs has reported a significant financial turnaround in Q4, posting a net profit of ₹148 million compared to a ₹413 million loss in the same quarter last year. The company's revenue increased by 11.76% year-on-year to ₹10.55 billion. Sequential growth was also strong, with Q4 profit up 127.69% from the previous quarter's ₹65 million.
26May 25
AKUMS DRUGS Achieves Remarkable Turnaround in Q4 Financial Performance
AKUMS DRUGS has reported a significant financial turnaround in Q4. EBITDA surged to ₹939.00 crore from ₹31.00 crore year-over-year. The company turned profitable with a net profit of ₹148.00 crore, compared to a loss of ₹413.00 crore in the previous year. Revenue increased to ₹10.55 billion from ₹9.44 billion. EBITDA margin improved to 8.90% from 0.33%, indicating enhanced operational efficiency.